EGF816 Exerts Anticancer Effects in Non-Small Cell Lung Cancer by Irreversibly and Selectively Targeting Primary and Acquired Activating Mutations in the EGF Receptor.
暂无分享,去创建一个
J. Barretina | Jennifer L. Harris | J. Engelman | P. McNamara | Chun Xing Li | S. Bender | N. Pathan | M. Vaillancourt | C. Costa | S. Kasibhatla | M. Didonato | R. Epple | E. Murphy | B. Bursulaya | D. Liao | Eric A. Murphy | T. Marsilje | J. Juarez | Yong Jia | Jie Li | Celin Tompkins | P. Michellys | Gérald Lelais | M. Niederst | Elizabeth Lockerman | M. Manuia | Noelito Timple | Matthew H. Mcneill | A. Pferdekamper | Jennifer Anderson | Jose C. Juarez | Mari Manuia